Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 11, 2025
Accession Number:
0001213900-25-021251
Submission Type:
POS AM
CIK:
0000907654
Company Name:
Oruka Therapeutics, Inc.
File Number:
333-283212